Epigenetic drug discovery is one of the fastest growing and potentially groundbreaking target spaces for developers. Over the past few years, a significant increase in small molecule inhibitors chemically modulating enzymatic activity of Histone Methyltransferases Histone Demethylases and disrupting interactions of the BET family bromodomains have rapidly translated into clinical investigation. Epigenetic drug discovery shows great promise for new drugs
Related Journals of Epigenetic Drug Discovery:
Drug Design, Development and Therapy, Drug Discovery Today: Therapeutic Strategies, Drug Development Research, Letters in Drug Design and Discovery, American Journal of Drug Discovery and Development, Drug Discovery World
Menu
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi